A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Clinical trial NCT02849951 · TERMINATED
Trial details
- NCT number
- NCT02849951
- Sponsor
- Prometheus Laboratories
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2019-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.